Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Walnuts May Prevent Breast Cancer

By LabMedica International staff writers
Posted on 29 Apr 2009
Walnut consumption may provide the body with essential omega-3 fatty acids, antioxidants, and phytosterols that reduce the risk of breast cancer, according to recent findings.

Elaine Hardman, Ph.D., associate professor of medicine at Marshall University School of Medicine (Huntington, WV, USA), reported that while her study was conducted with laboratory animals rather than humans, people should heed the recommendation to eat more walnuts. More...
"Walnuts are better than cookies, French fries, or potato chips when you need a snack," noted Dr. Hardman. "We know that a healthy diet overall prevents all manner of chronic diseases."

Dr. Hardman and colleagues studied mice that were fed a diet that they estimated was the human equivalent of about 57 g of walnuts per day. A separate group of mice were fed a control diet. Standard testing revealed that walnut consumption considerably decreased breast tumor incidence, the number of glands with a tumor and tumor size. "These laboratory mice typically have 100% tumor incidence at five months; walnut consumption delayed those tumors by at least three weeks," stated Dr. Hardman.

Molecular analysis showed that increased consumption of omega-3 fatty acids contributed to the decline in tumor incidence, but other parts of the walnut contributed as well. "With dietary interventions you see multiple mechanisms when working with the whole food," commented Dr. Hardman. "It is clear that walnuts contribute to a healthy diet that can reduce breast cancer."

The study's findings were presented at the American Association for Cancer Research 100th Annual Meeting 2009, held in Denver, CO, USA, in April 2009.

Related Links:

Marshall University School of Medicine



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.